These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25543372)

  • 1. [ACE inhibitors or ARBs for first-line treatment of arterial hypertension--who goes for the victory?].
    Trenkwalder P
    MMW Fortschr Med; 2014 Nov; 156(20):52-4. PubMed ID: 25543372
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use?
    Messerli FH; Bangalore S; Bavishi C; Rimoldi SF
    J Am Coll Cardiol; 2018 Apr; 71(13):1474-1482. PubMed ID: 29598869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Inquiry: Do ACE inhibitors or ARBs help prevent kidney disease in patients with diabetes and normal BP?
    Trietley GS; Wilson SA; Chaudhri P; Payette N; Higbea A; Nashelsky J
    J Fam Pract; 2017 Apr; 66(4):257-263. PubMed ID: 28375400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choose ARBs Over ACE Inhibitors for First-line Hypertension Treatment, Large New Analysis Suggests.
    Abbasi J
    JAMA; 2021 Oct; 326(13):1244-1245. PubMed ID: 34609454
    [No Abstract]   [Full Text] [Related]  

  • 5. [The clinical usefulness of RAAS inhibitors in hypertensive patients].
    Yamaguchi K; Sata M
    Nihon Rinsho; 2012 Sep; 70(9):1571-6. PubMed ID: 23012805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review.
    Bullo M; Tschumi S; Bucher BS; Bianchetti MG; Simonetti GD
    Hypertension; 2012 Aug; 60(2):444-50. PubMed ID: 22753220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema.
    Beavers CJ; Dunn SP; Macaulay TE
    Ann Pharmacother; 2011 Apr; 45(4):520-4. PubMed ID: 21427294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of ACE inhibition on all-cause and cardiovascular mortality in contemporary hypertension trials: a review.
    Ferrari R; Boersma E
    Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):705-17. PubMed ID: 23750680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mega clinical trials which have shaped the RAS intervention clinical practice.
    Düsing R
    Ther Adv Cardiovasc Dis; 2016 Jun; 10(3):133-50. PubMed ID: 27271312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers.
    Tazkarji B; Ganeshamoorthy A; Auten B
    Am Fam Physician; 2015 Feb; 91(3):193-4. PubMed ID: 25822274
    [No Abstract]   [Full Text] [Related]  

  • 11. How do angiotensin II receptor antagonists affect blood pressure?
    de Leeuw PW
    Am J Cardiol; 1999 Jul; 84(2A):5K-6K. PubMed ID: 10437737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination ACE inhibitors and angiotensin II receptor blockers for hypertension.
    Finnegan PM; Gleason BL
    Ann Pharmacother; 2003 Jun; 37(6):886-9. PubMed ID: 12773079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, and risk of appendicitis.
    Mukamal KJ; Ghimire S; Pandey R; Fiarman GS; Gautam S
    Ann Epidemiol; 2012 Oct; 22(10):747-50. PubMed ID: 22867943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angioedema related to Angiotensin inhibitors.
    Knecht SE; Dunn SP; Macaulay TE
    J Pharm Pract; 2014 Oct; 27(5):461-5. PubMed ID: 25124378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE Inhibitors vs ARBs for Primary Hypertension.
    Vega IL
    Am Fam Physician; 2015 Apr; 91(8):522-3. PubMed ID: 25884858
    [No Abstract]   [Full Text] [Related]  

  • 16. A retrospective study of the effects of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in diabetic nephropathy.
    Pathak JV; Dass EE
    Indian J Pharmacol; 2015; 47(2):148-52. PubMed ID: 25878372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ACE inhibitors continue to be first choice in the treatment of heart failure patients].
    Gadsbøll N; Pedersen CT
    Ugeskr Laeger; 2013 May; 175(22):1566-8. PubMed ID: 23721841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension: are they equivalent?
    Kaplan NM
    J Am Soc Hypertens; 2015 Aug; 9(8):582-3. PubMed ID: 26319536
    [No Abstract]   [Full Text] [Related]  

  • 19. Experience with angiotensin II antagonists in hypertensive patients.
    Waeber B; Burnier M; Nussberger J; Brunner HR
    Clin Exp Pharmacol Physiol; 1996 Sep; 23 Suppl 3():S142-6. PubMed ID: 21143288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renoprotection by angiotensin-receptor blockers and ACE inhibitors in hypertension.
    Opie LH
    Lancet; 2001 Dec; 358(9296):1829-31. PubMed ID: 11741617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.